The Team

Hans van der Voorn

Hans van der Voorn, Executive Chairman

Hans van der Voorn trained as an engineer in New Zealand and worked in civil engineering and
construction for 15 years. In 1994 he started the operation of Nova Gas Ltd in New Zealand,
originally based on methane extraction, processing and sale. Hans was a founder shareholder and
Chief Executive of Nova Gas until 2001, continuing as a non-executive director until 2006. Nova Gas
developed its own pipelines to bypass incumbent monopolies, became an integrated gas supply
company, is now wholly owned by Todd Energy and has a turnover in excess of NZ$250m.

In 2005 he became the sole financial investor in Izon Science. Originally a 50:50 joint venture with
the founder scientists, it is now owned by van der Voorn interests, private investors and Izon team
members.

In early 2007 Hans took over executive management of Izon, while the founder scientists continued
to work on research and development. He has developed Izon’s commercialization and sales
strategy and is also the inventor on one of Izon’s series of patent applications. He travels frequently
on behalf of Izon, is a regular speaker at conferences and investment forums and a regular
commentator on entrepreneurship and science commercialisation.

Hans van der Voorn is an experienced engineer and entrepreneur now wholly focused on Izon. His
ambition is for Izon to become a world leader in its chosen fields of particle and virus analysis. His
business philosophies are based on active two-way relationships between the Izon team and its
customers and partners.

Elliott Fellows, Business Manager

Elliott joined Izon Science in 2011 as Business Manager responsible primarily for the Financial and Administrative functions and with a commercial attitude towards the operation of the business. He is a qualified banker (ACIB) with 19 years experience working for HSBC across a wide variety of roles throughout the organization, including branch management and the internal audit function. He is also a qualified management accountant (ACMA) and was heavily involved with Planning, budgeting and forecasting at all levels of the bank, including the Retail, Corporate and Institutional banking sectors, as well having responsibility for the regular review of the UK Bank P&L and Balance sheet. He contributed towards significant in house systems development and spent a significant period of time training senior management in the use of the new HSBC management information system introduced to the UK in the 1990s.

Emigrating to New Zealand with his family in 2005 Elliott spent five years working for the Infiniti Capital Group as the Group Financial Controller. During this time Infiniti, a fund of hedge funds provider focusing in institutional clients, grew from a small Swiss family company, opening offices in NZ, UK, Switzerland and Hong Kong and incorporated up to 33 entities across countries worldwide.

Building, managing and developing a team of six managers and staff Elliott also designed and built a bespoke management information and budgeting system to allow detailed analysis of company performance, including the cross-entity review of the various company functions. He has first hand experience with the IFRS reporting standards across several countries as well as knowledge of International transfer pricing, taxation, business compliance and regulatory reporting.

Dr Sam Yu, Business Development Manager

Sam joined Izon in 2009 as Research and Business Development Manager. Since then he has
been engaged in technical & business development work with a number of Izon customers and
collaborators in Singapore, China, Australia, Taiwan, NZ and USA, including A*Star Institutes, MIT, NIST,
Johns Hopkins, Boston University, NMI and Aeras Vaccine Foundation. He has worked with these groups
on a wide range of application areas for Izon technology, from virology to drug delivery carriers. Sam was
also heavily involved in the R&D of Izon's new VPM system, which was launched in April 2010.

Sam has been involved in the bio-nanotechnology field for the past 10 years. Prior to joining Izon
he worked with Professor Alison Downard at UC and the MacDiarmid Institute for Nanotechnology,
in the creation of well defined chemical patterns of nano-layers of molecules and nanoparticles
to ‘smarten’ and functionalize materials. He has published papers in American, English and Japanese
journals.

Sam has a B.Sc (1st Hons) and Ph.D in Chemistry from University of Canterbury. He was honoured by
the New Zealand Government Tertiary Education Commission as a Top Achievers Doctoral Scholar
in 2004 and is also the recipient of the Fenwick Prize in Chemistry at UC. In 2005, he received an
Excellent Young Researcher Award from Japan’s Surface Science and Nanotechnology Society.

Dr Rebecca Warr, Research and Technical Support Manager

Rebecca is Izon’s Technical Support Manager and is responsible for post-sales training and support
to all users of Izon instruments. She has a strong customer focus and works with other members of
the Izon team in Christchurch to provide technical support for our customer base. She also brings
this user perspective to her involvement in the on-going product development for the qNano and
qViro , along with R & D for the SIOS platform. Rebecca joined Izon in June 2009.

Rebecca has over 10 years experience in scientific research, specializing in inorganic chemistry.
She has a B.Sc (1st Hons) from the University of Canterbury and a PhD from the Australian
National University. Following her PhD, she worked as a Postdoctoral Scientist at the University of
Nottingham, U.K., leading a team of scientists developing reagents for the transport of precious
metal chlorides for industrial applications.

Rebecca has been the recipient of a variety of scientific awards including the Don Stranks Award for
outstanding performance in research with a PhD candidature. Her academic research has resulted in
publications in both Angewandte Chemie and Inorganic Chemistry.

Dr. Yaniv Ganor, Research & Training Manager (United States)

Yaniv is a physicist and a systems engineer, with over ten years of experience in R&D activity. He mastered processes of design and realization of complex systems, with a special focus on remotely controlled micro actuators and sensors, and endovascular ultrasound diagnostics for medical devices applications.

Yaniv received his PhD from the Technion – Israel Institute of Technology in 2008 and joined the University of Minnesota as a postdoctoral research associate. His main area of research was the study of self-assembly synthesis and diffraction methods of morphologies based on the concept of objective structures (e.g. structure of viruses). In addition, he developed experimental methods and theoretical models for the study of the magneto-mechanical response of smart materials, with a special focus on high work output, remote actuation, and medical applications of these emerging materials. Yaniv also led a multi site, cross functional collaborative project that incorporated a novel bio-mimetic paradigm to improve the performance and robustness to lab on a chip and micro electro mechanical systems (MEMS), two competing goals in current micro/nano technology.

In 2011 Yaniv joined Izon Science as Research and Training Manager of North America, responsible for technical training and research activities of customers and partners of Izon, to the extent necessary for the development and integration of Izon’s products in the life sciences and healthcare.

Subhash Kalluri, Sales Scientist (United States)

Subhash joined Izon Science in August 2011 as Sales Scientist for North Carolina. He is very excited about his new role in sales and looking forward to making a difference in the US market. Prior to joining Izon Science, he worked as Research Associate in a North Carolina based Nano-Biotechnology Company called Nanomedica Inc, where he worked on developing ultra-sensitive detection reagents.

He graduated from Old Dominion University in 2010 and worked as Graduate Research Assistant in the Frank Reidy Research Center for Bioelectrics for two and a half years. During his time at the center, he was involved in developing a novel method for cancer treatment using Multi-Walled Carbon Nanotubes and ultra-short electric pulses and understanding the dispersion of Multi-Carbon Nanoparticles in detergent and water.

Professor David Williams

Professor David E Williams is a member of the Chemistry Dept at Auckland University, a Visiting
Professor at both University College London, where he has strong research links, and University
of Southampton, and an Honorary Professor of the Royal Institution of Great Britain. His current
research interests include new medical diagnostic tools and electrochemistry of modified liquid-
liquid interfaces. He has published around 200 papers in international journals, and is inventor on
around 40 patents.

David provides specialist advice to Izon in the development and application of nanopores for
diagnostic and drug delivery platforms. Two key projects that David is leading focus on advanced
techniques for nanopores fabrication, and the kinetics of immunoassays by studying aggregation
through specific particle binding.

David is a graduate of the University of Auckland. He developed his research career in
electrochemistry and chemical sensors at the UK Atomic Energy Research Establishment, Harwell,
in the 1980s. He then became Thomas Graham Professor of Chemistry at University College London
in 1991 and co-founded Capteur Sensors Ltd. From 1999 -2002 he was Head of the Chemistry Dept
at UCL and co-founded Aeroqual Ltd (www.aeroqual.com), and then Chief Scientist of Inverness
Medical Innovations ( www.invernessmedical.com/ ), based at Unipath Ltd, Bedford, UK, from 2002-
2005.

Professor David Patterson

Professor David Paterson is currently Professor of Cardiovascular Physiology and Associate Head of
the Division at Oxford University. He also leads the Paterson Research Group in the area of cardiac
neurobiology. A main research focus for the Group is how both branches of the cardiac autonomic
nervous system communicate at the end organ level and whether oxidative stress plays a role in
uncoupling pre-synaptic and post synaptic signalling. This has led to the development of a method
for targeting the enzyme involved in making nitric oxide, using a gene transfer approach involving
cell specific viral vectors, to study the physiology of this messenger in normal and diseased hearts.

David completed his doctoral studies in physiological sciences at Oxford in the eighties, having
been a graduate of the University of Otago and the University of Western Australia. He received his
Doctor of Science degree from Western Australia in 2005 and was made a Fellow of the Institute
of Biology in 2003. Following an MRC post doc in Oxford and a BHF lectureship he was appointed
to a University Lectureship in 1994 and made a Fellow of Merton College. He Chairs the Divisions
Personnel Committee and is also the Chairman of the editorial board of Experimental Physiology and
is a member of the BHF project grants committee.

David provides advice to Izon on the potential of our technology platform for use in medical
research, particularly in relation to gene therapy.